Agent for treating acute upper respiratory infection

Abstract

The invention relates to an agent for treating acute upper respiratory infection. The agent is prepared from euphorbia kansui, liquorice, szechuan lovage rhizome, astragalus, dried ginger, fructus cnidii, divaricate saposhnikovia root, radix tinosporae, Indian iphigenia bulb, herba orostachyos, radix ophiopogonis, polygala tenuifolia, madder, the seed of cowherb and moutan bark. The agent for treating acute upper respiratory infection is reasonable in formula, simple and readily available in components and obvious in curative effect and does not have an obvious side effect.

Description

technical field [0001] The invention relates to the field of internal medicine, in particular, the invention relates to a medicament for treating acute upper respiratory tract infection. Background technique [0002] Acute upper respiratory infection is a general term for acute inflammation of the nasal cavity, pharynx or larynx. Common pathogens are viruses, and a few are bacteria. There are no age, gender, occupation and regional differences in its incidence. Generally, the condition is mild, the course of the disease is short, and the prognosis is good. However, due to the high incidence and certain infectivity, it not only affects the production labor force, but also sometimes produces serious complications, so it should be actively prevented and treated. The disease can occur throughout the year, but it occurs frequently in winter and spring. It can be transmitted through virus-containing droplets or contaminated hands and utensils. It is mostly sporadic, but it can ...

AI Technical Summary

Problems solved by technology

However, due to the high incidence and certain infectivity, it not only affects the production labor force, but also sometimes produces serious complications, so it should be actively prevented and treated.

Images